More European HTA collaboration likely, but no EuroNICE
This article was originally published in SRA
Executive Summary
It seems likely that there will be more collaboration on healthcare technology assessments across the EU in a bid to reduce the 27 plus "hurdles to market access" following marketing approval1. However, a "EuroNICE" that would rule on cost-effectiveness for all member states is unlikely.